Brufsky, A.M., et al. (2013) EMILIA trial: T-DM1 in metastatic breast cancer.
http://www.onclive.com/peer-exchange/MBC-challenges/EMILIA-Trial-T-DM1-in-Metastatic-Breast-Cancer

has been cited by the following article:

• TITLE: Accessory breast poorly differentiated adenocarcinoma with positive HER2 gene amplification: A case report

  AUTHORS: Dinesh Francis Balasingam, Ramesh Thangaratnam, Joel Sateeish Kumar

  KEYWORDS: Accessory Breast; Breast Cancer; Accessory Breast Cancer; HER2 Gene

  JOURNAL NAME: Case Reports in Clinical Medicine, Vol.3 No.2, February 8, 2014

  ABSTRACT: Background: Primary poorly differentiated adenocarcinoma of the accessory breast is rare. We report such a case in a 56-year-old Malaysian woman of Indian ethnicity. Case Presentation: An axillary swelling measuring 5 × 5 cm on excisional biopsy revealed a poorly differentiated adenocarcinoma with positive HER2 gene amplification. Conclusion: Overall prognosis is similar to that of a carcinoma of the normal breast, therefore early diagnosis is imperative to ascertain curable status and improve prognosis.